Introduction
Epileptic disorders are the clinical result of excitatory and inhibitory system imbalance within the central nervous system. 1 Surgical removal of the epileptic focus is widely accepted as an effective therapy for selected patients with medically refractory epilepsy; however, there is no consensus regarding accurate predictors of surgical outcome due to the use of heterogeneous study groups, differences in surgical procedures and duration of follow-up, and varying definitions of surgical success and failure.
The primary measure of the outcome of epilepsy surgery (ES) is the end of seizures, and secondary outcome measures are the frequency and severity of seizures, quality of life, level of disability, and mortality. [2] [3] [4] [5] Transcranial magnetic stimulation (TMS) has been used to non-invasively and almost painlessly investigate the human cerebral cortex. The motor threshold (MT) and cortical silent period (CSP), and intracortical inhibition and intracortical facilitation have been used to evaluate motor cortex excitability. 6 Cortical excitability is likely to change after surgical removal of the epileptic focus; 7, 8 therefore, TMS parameters may be useful for predicting the outcome of ES. The present study aimed to assess the value of the MT and CSP as predictors of the outcome of temporal lobe epilepsy surgery (TLES).
Materials and methods
The study included 10 patients (8 female and 2 male) aged 25-39 years (mean age: 30.7 years) with drug-resistant temporal lobe epilepsy ( Table 1 
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(v-EEG) monitoring, brain magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT), and positron emission tomography (PET), and neurophysiological testing. All of the patients provided written informed consent to undergo TLES, and TMS testing before and after TLES. The Gü lhane Military Medical Hospital Ethics Committee approved the study protocol. Patients 1 and 5 underwent anteromedial temporal lobectomy (AMTL), and the others underwent AMTL and amygdalohippocampectomy (AHCT). During AMTL, 3.5 cm of the temporal pole (from the temporal tip) was removed, including half of the superior temporal gyrus, and the middle and inferior temporal gyri. During AHCT, the amygdala, anterior part of the tail of the hippocampus, and the entire head and body of the hippocampus and parahippocampal gyrus were surgically removed. Following surgery, the patients' antiepileptic drug (AED) regimens remained unchanged. Additionally, pre-surgical and post-surgical AED blood levels were identical and within therapeutic ranges. Patient characteristics are shown in Table 1 .
TMS testing was performed 7 days prior to surgery by a neurologist blinded to the location of each patient's epileptic focus. TMS testing was repeated 3 months post surgery by another neurologist blinded to the pre-surgery measurements. TMS testing in patients 4 and 7 -whose seizures persisted post TLES -was performed at least 3 days after they had seizures. TMS was performed while the patients were in a seated position, using a 9-cm diameter circular coil (Dantec MC125) capable of generating a peak magnetic field of 1.0 T. Responses of the abductor pollicis brevis (APB) muscles were recorded bilaterally with a Dantec Evolution EMG apparatus, using Ag-Cl surface electrodes. The coil was placed over the scalp projecting the motor cortex area about 7 cm lateral of the vertex. The position of the coil was changed slightly and the stimulus was administered until the optimal position for APB muscle response was determined.
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MT measurement
MT was defined as the lowest intensity stimulus required to elicit an MEP 50 AE 10-mV in amplitude from the resting APB muscle, with !5 successful trials out of 10. Initial stimulus intensity was 30% of the maximum stimulus intensity and was increased by 1-5% until we obtained the MT. MT was measured for both APB muscles independently.
CSP measurement
CSP-150 and CSP-max measurements were obtained for each patient. During the procedure patients were requested to contract their APB muscles using 50% of their maximum contraction force. For CSP-150 measurement the stimulus intensity was adjusted to 1.5-fold that of the MT measurement for the same APB muscle and was administered from the contralateral side of the scalp during contraction of the ABP muscle. CSP-150 was defined as the mean value of 5 measurements and CSP-max was defined as the mean value of 5 CSP measurements obtained with the maximum stimulus intensity. [9] [10] [11] [12] Seizure-free was defined as no seizure during the follow-up period. Pre-and post-surgical MT and CSP measurements were compared, in terms of the side of epileptic focus and the contralateral side. Statistical evaluation of the data acquired before and after surgery was performed using the paired t test.
Results
None of the patients experienced complications during TMS testing. Mean pre-surgical MT (as a percentage of maximum stimulus intensity) was 52.7 AE 2.6% on the ipsilateral side and 53.3 AE 1.7% on the contralateral side. Post-surgical MT was 53.4 AE 2.9% on the ipsilateral side and 51.7 AE 1.6% on the contralateral side (Table 2) . Pre-and post-surgical MT values for the ipsilateral and contralateral sides did differ significantly (P = 0.42 and P = 0.04, respectively). Pre-surgical mean CSP-150 was 145.7 AE 11.3 ms on the ipsilateral side and 146.3 AE 10.1 ms on the contralateral side. Post-surgical mean CSP-150 was 142.3 AE 12.2 ms on the ipsilateral side and 137.2 AE 12.2 ms on the contralateral side. Differences were not noted between pre-and post-surgical CSP-150 values on the ipsilateral side, but post-surgical mean CSP-150 on the contralateral side was significantly shorter than the pre-surgical value (P = 0.19 and P = 0.008, respectively).
Pre-surgical mean CSP-max was 153.7 AE 11.2 ms on the ipsilateral side and 157.2 AE 12.1 ms on the contralateral side. Postsurgical mean CSP-max was 147.6 AE 11.8 ms on the ipsilateral side and 142.2 AE 12.2 ms on the contralateral side. Post-surgical mean CSP-max on the ipsilateral and contralateral sides was significantly shorter than the pre-surgical values (P = 0.011 and P = 0.007, respectively). Additionally, mean CSP-max was significantly longer than mean CSP-150 on the contralateral side post-surgically (P = 0.005). CSP results are summarized in Table 3 .
Post surgery, the patients continued to receive the same AED treatment they received pre-surgery. Mean duration of follow-up was 28.8 months (range: 11-57 months); 8 patients were seizurefree post TLES, whereas patients 4 and 7 had no reduction in seizure frequency or severity (Table 1) .
Discussion
The present study's results indicate that the post-TLES CSP -not MT -was shorter in the 8 patients that were seizure-free post TLES. Patients 4 and 7 had no improvement in seizure frequency or seizure severity post surgery and their MT and CSP values before and after ES were similar.
Epileptic disorders are characterized by heterogeneous pathophysiological processes that lead to alteration in the balance between excitatory and inhibitory influences at the cortical level. It has been proven that AEDs can alter the MT and CSP in epilepsy patients by reorganizing cortical excitability. The MT has been reported to be low, normal, and high in epilepsy patients. Many studies have suggested that the discrepancy between MT measurements might be due to the fact that the MT is a dynamic phenomenon that varies according to seizure type. Although the results of studies on the effects of AEDs on the MT are inconsistent, CSP duration has been reported to decrease following AED treatment, 13, 14 which may be a result of the close relationship between the CSP and the GABAergic system. GABA-A receptors mediate short-duration inhibitory postsynaptic potentials (IPSPs), whereas GABA-B receptors mediate long-duration IPSPs. Some researchers propose that CSP duration is an indicator of GABA-B receptor-mediated motor cortical inhibition.
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The epileptic focus can affect excitatory and inhibitory mechanisms on both the ipsilateral and contralateral sides. Several studies on focal epilepsy support the notion that the epileptic focus has bilateral effects that may be stronger on the contralateral side. The mechanisms underlying these changes remain to be elucidated; a low local inhibitory level caused by the presence of an excitatory epileptic focus is 1 hypothesis. 9, 17, 18 As with AED treatment, surgical excision of the epileptic focus can reorganize cortical excitability. Lä ppchen et al. were the first to study changes in cortical excitability following successful ES. 9 They observed that the MT on the ipsilateral side was significantly higher than that on the contralateral side following successful ES. In the present study no differences in MT on both the ipsilateral and contralateral sides were observed before and after TLES. Such contradictory results may be related to the surgical procedures employed or the dynamic nature of the MT. On the other hand, Lä ppchen et al. reported that the CSP was prolonged on the ipsilateral side before ES, which indicates that the epileptic focus has a significant affect on the contralateral hemisphere, and that the changes on the ipsilateral side were comparatively minor. The CSP was significantly shorter on the contralateral side after successful ES, indicating that there was a reduction in intracortical inhibition on the contralateral side following ES. 9 In the present study CSP-150 and CSP-max on the contralateral side were shorter in the 8 patients that were seizure-free during post-surgical follow-up; however, although v-EEG monitoring, brain MRI, SPECT, and PET, and neurophysiological testing facilitated identification of the epileptic foci, TLES failed in 2 patients (patients 4 and 7) that had no improvement in seizure frequency or severity during follow-up. Surprisingly, although the epileptic focus in patient 4 was located on the left side before surgery, v-EEG monitoring performed 14 months post surgery showed that the epileptic focus was on the left side. Furthermore, MT, CSP-150, and CSP-max measurements on the ipsilateral and contralateral sides pre-and post surgery did not differ in patients 4 and 7. Additionally, as both CSP-150 and CSP-max measurements on the contralateral side were the same, we recommend using CSP-150 instead of CSP-max in order to avoid the potential side-effects of TMS testing.
Researches have shown that TLES can result in complete seizure remission rates of up to 80% in patients with mesial temporal sclerosis and unilateral seizures. The seizure-free rate after TLES in patients with extratemporal non-lesional epilepsy is 30-40%. 19 The duration of post-surgical follow-up is important in determining seizure-free and quality of life outcomes following TLES. It has been suggested that outcome at 1 year post TLES is a good predictor of long-term outcome. [20] [21] [22] [23] [24] The main limitations of the present study are the small number of patients and the lack of final diagnoses supported by histopathology. Additionally, the present results may have been affected by the different surgical procedures employed; however, the surgical procedures were chosen based on the tests used to evaluate the patients and identify the epileptic foci, and the clinical experience of the neurosurgeons. Larger well-designed studies are needed in order to obtain more definitive results. There is a possibility that TMS testing in the 2 patients that still had seizures post surgery may have contributed to the persistence of the seizures; however, we think it unlikely as we performed TMS testing 5 days after seizure in patient 4 and 9 days after seizure in patient 7. Although the duration of post-surgical follow-up is essential for the assessment of seizure-free outcome of TLES, the present results indicate that evaluation of the difference between pre-and post-TLES CSP may be predictive of clinical outcome. Although the present study group was small, the findings in patients 4 and 7 indicate that unaltered CSP values following TLES may be related to a poor outcome; however, the results of this small-scale feasibility study indicate that CSP may be a useful predictor of longer-term post surgical outcome and that larger prospective studies are warranted.
